← Back to Search

Stress and Communication Skills Training for Cancer

N/A

Waitlist Available

Led By Kelly Trevino, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of poor prognosis advanced cancer defined as: (1) locally advanced or metastatic cancer (i.e., thoracic, gynecological, genitourinary cancer, pancreatic or lymphoma) or (2) disease progression following at least first line treatment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will test an intervention to help manage difficult emotions and communicate about the patient's illness. The intervention is designed to be culturally sensitive and reduce burden to patients, caregivers, and healthcare institutions.

Who is the study for?

This trial is for Latino/a patients with advanced cancer and their caregivers, who are fluent in English or Spanish, reside in New York, and can communicate by phone. Patients must have discussed prognosis with their oncologist and not be receiving hospice care. Caregivers need to provide support without pay and have experience working with advanced cancer patients.Check my eligibility

What is being tested?

The study tests a stress management and communication skills intervention tailored for Latinx individuals versus a non-tailored version. Participants will attend weekly 45-minute sessions designed to improve emotional handling, quality of life, understanding of illness, and treatment preferences discussions.See study design

What are the potential side effects?

Since this is a psychosocial intervention involving counseling sessions rather than medication or medical procedures, traditional side effects are not expected. However, discussing sensitive topics may evoke emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I'm sorry, but it seems like you didn't provide any criterion for me to rewrite. Could you please provide the criterion you would like me to summarize?

Select...

My advanced cancer has a poor prognosis and has either spread or not responded to first treatment.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of patient-caregiver communication-based intervention defined by participant enrollment

Feasibility of patient-caregiver communication-based intervention defined by participant retention

Trial Design

2Treatment groups

Experimental Treatment

Group I: PatientsExperimental Treatment1 Intervention

Latino/a advanced cancer patients

Group II: CaregiversExperimental Treatment1 Intervention

Caregivers of Latino/a advanced cancer patients

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,575 Total Patients Enrolled

Weill Medical College of Cornell UniversityOTHER

1,054 Previous Clinical Trials

1,316,483 Total Patients Enrolled

Kelly Trevino, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

2 Previous Clinical Trials

77 Total Patients Enrolled

Media Library

Weekly 45 minute Sessions Clinical Trial Eligibility Overview. Trial Name: NCT03794635 — N/A

Cancer Research Study Groups: Patients, Caregivers

Cancer Clinical Trial 2023: Weekly 45 minute Sessions Highlights & Side Effects. Trial Name: NCT03794635 — N/A

Weekly 45 minute Sessions 2023 Treatment Timeline for Medical Study. Trial Name: NCT03794635 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a current opportunity to participate in this trial?

"Clinicaltrials.gov confirms that this experiment is no longer recruiting patients, which began on the 20th of December 2018 and was edited as recently as August 19th 2022. Nevertheless, 1997 other trials are still actively looking for volunteers at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

2018. "An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03794635.

All > Lung Cancer Philadelphia > Lymphoma